Home / Japan / OncoTherapy Science,Inc.
OncoTherapy Science,Inc.
No short position is open on this share today.
0.00% of the capital sold short
0 disclosing funds
16 disclosures on record
Evolution of the disclosed total
0%0.5%1%1.5%2%
Aug 12Aug 21Aug 30Sep 8Sep 17
Open positions
No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.
Get the moves on OncoTherapy Science,Inc. by mail.
No account: one address, one link to confirm, one link to stop in every message.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| August 31, 2026 | JPM Securities Japan Co Ltd. | 0.49% | |
| August 21, 2026 | Barclays Capital Securities Ltd | 0.30% | |
| August 18, 2026 | JPM Securities Japan Co Ltd. | 0.57% | |
| August 18, 2026 | 個人 | 0.00% | |
| August 17, 2026 | Barclays Capital Securities Ltd | 0.52% | |
| August 14, 2026 | JPM Securities Japan Co Ltd. | 0.60% | |
| August 14, 2026 | Barclays Capital Securities Ltd | 0.48% | |
| August 13, 2026 | Barclays Capital Securities Ltd | 0.50% | |
| August 10, 2026 | Barclays Capital Securities Ltd | 0.49% | |
| August 7, 2026 | JPM Securities Japan Co Ltd. | 0.51% | |
| August 7, 2026 | モルガン・スタンレーmufg証券株式会社 | 0.48% | |
| August 6, 2026 | モルガン・スタンレーmufg証券株式会社 | 0.53% | |
| August 6, 2026 | JPM Securities Japan Co Ltd. | 0.49% | |
| August 5, 2026 | モルガン・スタンレーmufg証券株式会社 | 0.67% | |
| August 3, 2026 | Barclays Capital Securities Ltd | 0.58% | |
| August 3, 2026 | JPM Securities Japan Co Ltd. | 0.50% |
Download 16 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in Japan
- ReYuu Japan Inc. 12.36% of the capital sold short
- Towa Corporation 10.49% of the capital sold short
- TESS Holdings Co.,Ltd. 6.97% of the capital sold short
- Unitika LTD. 6.96% of the capital sold short
- Jibannet Holdings Co.,Ltd. 6.90% of the capital sold short
- Nomura Micro Science Co.,Ltd. 6.52% of the capital sold short
- Toyo Engineering Corporation 6.29% of the capital sold short
- JSH Co.,Ltd. 5.97% of the capital sold short
- Datasection Inc. 5.83% of the capital sold short
- Def consulting,inc. 5.76% of the capital sold short
- Tri Chemical Laboratories Inc. 5.71% of the capital sold short
- Toho Zinc Co.,Ltd. 5.27% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, OncoTherapy Science,Inc., source JPX, data as at August 31, 2026, https://www.quivad.com/action/oncotherapy-science-inc